Caitong International Asset Management Co., LTD Allakos Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Allakos Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 754 shares of ALLK stock, worth $233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
754
Previous 754
-0.0%
Holding current value
$233
Previous $912,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALLK
# of Institutions
81Shares Held
69.2MCall Options Held
47.3KPut Options Held
1K-
Bvf Inc San Francisco, CA16.6MShares$5.13 Million0.75% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$1.91 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.7MShares$1.77 Million0.3% of portfolio
-
Lynx1 Capital Management LP San Juan, PR3.63MShares$1.12 Million1.7% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.59MShares$1.11 Million0.01% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $26.3M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...